Zero Trust Security Implementation for Pharmaceutical Industry

This solution brief outlines the implementation of zero trust security within the pharmaceutical industry to address the vulnerabilities arising from digital transformation. It discusses the significant financial investment forecasted by the pharmaceutical sector in digital transformation by 2030, with the aim of achieving enhanced therapeutic innovations and production processes. The brief describes how traditional security measures are inadequate in the current landscape where IT and operational technology (OT) systems are increasingly interconnected. It defines zero trust security as a strategy that presumes breaches have occurred, necessitating strict controls over user access and network traffic. Furthermore, the document emphasizes the importance of network segmentation in blocking lateral movement of malware and ransomware across both IT and OT networks. It explains how ColorTokens provides a unified approach to managing security across these networks, ensuring that organizations can protect their critical assets while complying with regulatory requirements. The approach is positioned as essential for enhancing resilience and minimizing cybersecurity risks.